<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: January Transactions</title>
	<atom:link href="http://stockherd.com/moosepond/2006/01/january-transactions/feed/" rel="self" type="application/rss+xml" />
	<link>http://stockherd.com/moosepond/2006/01/january-transactions/</link>
	<description>Online Journal for the Moose Pond Investors Club</description>
	<lastBuildDate>Tue, 12 Feb 2008 02:58:15 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0</generator>
	<item>
		<title>By: Susan</title>
		<link>http://stockherd.com/moosepond/2006/01/january-transactions/comment-page-1/#comment-25</link>
		<dc:creator>Susan</dc:creator>
		<pubDate>Tue, 24 Jan 2006 20:06:20 +0000</pubDate>
		<guid isPermaLink="false">http://stockherd.com/moosepond/?p=93#comment-25</guid>
		<description>Stryker looks like a promising buy with a few concerns.  Latest quarter figures show sales growth at 13.9, however you projected at 14.5 percent going forward.  What indicators do you see that will allow the company to meet these figures?  Also section 2B shows a downward trend.  What is causing this?  Do you see it as a concern?  What is the industry norm?  That being said, I see this company as one of the industry leaders.  The wild card is that the market is predicting that the next growth phase will come from the spinal disc arena and although there are a few contenders for the lead at this time, only time will tell as it plays out.

Coco Cola seems to have resumed its high single digits growth, again, section 2B is shrinking and in section 3, both high and low pe&#039;s are decreasing.  In section 4, therefore I would have dropped both the high and low pe going forward. The high PE probably to the average.
</description>
		<content:encoded><![CDATA[<p>Stryker looks like a promising buy with a few concerns.  Latest quarter figures show sales growth at 13.9, however you projected at 14.5 percent going forward.  What indicators do you see that will allow the company to meet these figures?  Also section 2B shows a downward trend.  What is causing this?  Do you see it as a concern?  What is the industry norm?  That being said, I see this company as one of the industry leaders.  The wild card is that the market is predicting that the next growth phase will come from the spinal disc arena and although there are a few contenders for the lead at this time, only time will tell as it plays out.</p>
<p>Coco Cola seems to have resumed its high single digits growth, again, section 2B is shrinking and in section 3, both high and low pe&#8217;s are decreasing.  In section 4, therefore I would have dropped both the high and low pe going forward. The high PE probably to the average.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.309 seconds -->
